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ABSTRACT
Several studies in the last years demonstrated the better surgical outcome of 
laparoscopic approach to adrenal gland. Laparoscopic surgery is more difficult to 
learn and requires different psychomotor skills than open surgery, especially with 
regard to complex maneuvers requiring precision and dexterity. The development of 
robotic platform with three-dimensional vision and increased degrees of freedom of 
the surgical instruments has the aim to overcome these problems. We performed a 
systematic literature review with meta-analysis to evaluate preoperative data and 
surgical outcomes of robotic adrenalectomy compared with laparoscopic technique.  
In September 2016 we performed a systematic literature review using the Pubmed, 
Scopus and ISI web of knowledge database with search term “robotic adrenalectomy”. 
We identified 13 studies with eligible criteria that compared surgical outcomes. This 
present systematic review with meta-analysis includes 798 patients: 379 underwent 
to robotic adrenalectomy (cases group) and 419 to laparoscopic adrenalectomy 
(controls group). There were no significant differences between the two groups of 
patients respect to age, gender, laterality and tumor size. BMI instead was significant 
lower in the robotic group. In this group we found also patients with higher incidence 
of previous abdominal surgery. The results from operative time demonstrated lower 
operative time for laparoscopic group but there were no significant differences with 
robotic group.  Robotic adrenalectomy showed a significant lower blood loss.  Robotic 
adrenalectomy is a safe and feasible technique with reduced blood loss and shorter 
hospital stay than laparoscopic adrenalectomy. Laparoscopic approach seems to be a 
more rapid technique when comparing to robotic technique, although recent studies 
demonstrate a significant operative time reduction in robotic group with the learning 
curve improvement and the development of new surgical technology.
                                                         Meta-Analysis
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INTRODUCTION
Since the first description by Gagner in 1992 [1] 
laparoscopic adrenalectomy (LA) became the standard 
treatment for adrenal removal. Several studies in the 
last years demonstrated the better surgical outcome of 
laparoscopic approach to adrenal gland such as decrease 
of the perioperative morbidity, lower complication rate, 
less operative blood loss, less perioperative pain and 
short hospital stay compared with open adrenalectomy for 
several indications [2–5]. Some questions remain about 
treatment of large adrenal masses with increased risk of 
adrenocortical carcinoma (ACC) [6]. Laparoscopic surgery 
is more difficult to learn and requires different psychomotor 
skills than open surgery. In fact, the surgeons have to work 
in a three-dimensional space, but are guided by two-
dimensional images. This limitation can be challenging, 
especially with regard to maneuvers requiring precision and 
dexterity [7]. For this reason in the last period the use of 
a new generation three-dimensional (3D) HD laparoscopic 
system can improved quality of vision [8, 9, 10], but as 
the current laparoscopic technology is limited in regard 
to the maneuverability and inferior ergonomic design 
of instruments, natural surgical strain, tremors and the 
counterintuitive movements. The development of robotic 
platform has the scope to overcome these problems. In 1999 
Piazza et al. [11] published the first case of robot-assisted 
right adrenalectomy in a patients with Conn’s syndrome 
using the ZEUS AESOP (Computer Motion, Inc., Santa 
Barbara, CA). With the introduction of the da Vinci system 
(Intuitive Surgical, Sunnyvale, CA, USA) several series of 
robotic surgery have been reported. In recent years robotic 
adrenalectomy (RA) has received attention to the perceived 
benefits of this technology with three-dimensional vision, 
the elimination of surgeon’s tremor and increased degrees 
of freedom of the surgical instruments, a comfortable sitting 
position. Nonetheless, robotic surgical operations seem 
to have longer operative time and more expensive costs 
compared with traditional laparoscopic surgery. In recent 
years several authors described cases series of robotic 
approach to adrenal surgery compared with traditional LA 
and demonstrated safety and feasibility of robotic procedure 
with different results in term of operative time, blood loss, 
conversion rate, complications and length of hospital stay. 
Nevertheless, these reports did not consider short and long-
term outcomes so we performed a systematic literature 
review with meta-analysis to compare preoperative 
differences and surgical outcomes between RA and LA.  
MATERIALS AND METHODS
Literature search and study selection
In September 2016 we performed a systematic 
literature review using the Pubmed, Scopus and ISI web of 
knowledge database to identify all studies that compared 
RA and LA. The search was done using the term “robotic 
adrenalectomy”. We considered only publications in 
English language that compared robot-assisted and 
laparoscopic adrenalectomy. Conference abstracts, cases 
series, non comparative studies and comparison with open 
surgery were not included in this meta-analysis. When two 
or more studies were published by the same authors and/
or institution with a potentially overlapping patient sample 
and with the same outcome we considered the most recent. 
Three independent reviewers completed this process with 
analysis of cited references from the selected articles to 
identify other significant articles.
Study quality assessment
The level of evidence of included studies was rated 
according to the criteria of the Centre for Evidence-
Based Medicine [12]. The methodological quality of all 
nonrandomized studies was assessed using the Newcastle-
Ottawa Scale [13]. A score of 0–9 may be given to 
individual studies. Studies achieving a score of 7 or more 
indicated a higher quality . Three reviewers (AA, GR and 
GDB) independently assessed the quality of the study 
and solved disagreement by consensus. We identified 
13 studies [14–26] with eligible criteria (Figure 1) that 
compared RA versus LA and clinical outcomes. 
Data extraction and outcomes of interest
The clinical outcomes that were analyzed and 
compared among RA and LA included preoperative 
demographic characteristics like age, gender, body mass 
index (BMI); tumors size and laterality, surgical indication 
and pathology specimens; history of previous abdominal 
surgery; specific surgical approach to adrenal gland (lateral 
transperitoneal versus retroperitoneoscopic). Surgical 
results such as operative time, blood loss, conversion rate, 
complications and length of hospital stay were considered 
indirect objective signs of surgical precision and safety.
Statistical analysis
A meta-analysis was performed to identify 
clinical outcomes and potentially surgical advantages 
of RA when compared with traditional LA. This 
analysis follows the recommendations of the Cochrane 
Collaboration using R Statistical Software (R ver 
3.3.1, R Foundation for Statistical Computing, Vienna, 
Austria). Odds ratio (OR) was used for dichotomous 
variables and mean difference or standardized mean 
difference for the continuous parameters. All outcomes 
were reported with 95% confidence interval (95% 
CI). However some studies did not report any of these 
parameters, but presented continuous data as medians. 
In these cases we made an approximate transformation 
using Hozo methodology [27]. An OR significantly < 1 
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favored RA, whereas an OR significantly > 1 favored 
LA. All P values < 0.05 was considered statistically 
significant. Pooled estimates were calculated with the 
fixed-effect model (Mantel-Haenszel method) [28] if 
no significant heterogeneity was detected; otherwise, 
the random-effect model (DerSimonian-Laird method) 
was used [29]. The Cochrane chi-square test (Q) 
and inconsistency (I2) were used to evaluate the 
heterogeneity among studies.
RESULTS
From our systematic literature review we identified 
13 studies that compared RA and LA including 798 
patients. 379 underwent to RA (cases group) and 419 
to LA (controls group). 8 studies were prospective, but 
only one was a randomized controlled trial. 5 studies 
instead were retrospective. In Table 1 we showed studies 
characteristics, year and country of publication, period 
of study interval and level of evidence. We divided 
the variables analyzing in three groups: preoperative; 
operative and surgical outcomes. We considered also 
follow up and costs of RA but there was a lack of data 
regarding these aspects.
Demographics and preoperative characteristics
There were no significant differences between the 
two groups of patients respect to age, gender, laterality 
and tumor size. BMI instead was significant lower in the 
robotic group (Figure 2A). In robotic group we found 
patients with higher incidence of previous abdominal 
surgery (Figure 2B) but there was no significant difference.
Operative variable
In this category we considered the surgical 
technique in the preferred approach among the two groups 
with no significant differences. The results from operative 
time demonstrated lower operative time for LA but 
there were no significant differences with robotic group 
(Figure 3A). RA instead showed a significant lower blood 
loss (Figure 3B).
Surgical outcomes
There were no differences in term of pathological 
results. Overall complications and conversion rate were 
expression of surgical safety and seemed to be favoring 
of RA but with no significant differences (Figure 4A-4B ). 
Length of hospital stay was significant lower in robotic 
arm (Figure 4C). In this study we tried to analyze also 
follow-up and costs of different procedures, robotic and 
laparoscopic, but there was no systematic data compilation 
in eligible articles so we were not able to perform a 
rigorous meta-analysis.
DISCUSSION
Since first LA in 1992 [1] endocrine surgeons 
developed interest for mini-invasive surgery thanks to 
better clinical outcomes, lower perioperative morbidity 
and mortality, shorter hospitalization and better cosmetic 
results [30]. In 1999 Piazza et al. [11] demonstrated the 
feasibility of robot-assisted adrenalectomy using ZEUS 
AESOP (Computer Motion, Inc., Santa Barbara, CA). For 
many years technology made numerous improvements in 
robotic platform with the advent of da Vinci system 
(Intuitive Surgical, Sunnyvale, CA, USA) that allowed 
worldwide diffusion of robotic surgery, initially for radical 
prostatectomy and later for several surgical procedures 
especially for those requiring advanced surgical skills like 
sutures and intracorporeal knotting [31]. Robotic platforms 
present numerous advantages like endo-wrist movements 
with 7 degrees of freedom, absence of surgeon related 
tremors and stereoscopic vision. Although LA is a safe and 
diffuse procedure among endocrine surgeons, we 
performed this systematic literature review with meta-
analysis comparing laparoscopic and robotic approach. We 
considered particular deep location of adrenal loggia with 
theoretical maximum advantage of 3D vision system and 
endo-wrist movements. These characteristics could be 
reasonably used in complex patients (previous surgery, 
BMI > 30 kg/m2). The large diffusion of RA was clear 
from our literature research with several cases series in the 
last years. We found other two meta-analysis that 
compared RA and LA but these studies took in 
consideration initial limited experience in RA [32, 33] and 
obtained some different results. Furthermore, we had to 
consider the evolution of robotic platform and 
consequently the differences in surgical results. We did not 
found significant differences in demographics and 
preoperative characteristics except for BMI and history of 
previous surgery. We observed lower BMI and higher 
incidence of previous abdominal surgery in robotic group. 
From literature we knew that obesity represents an 
independent risk factor in adrenal surgery [34]. The most 
articles analyzed in this study were not randomized and the 
difference in BMI seemed to be a bias in patient selection 
because surgeons choosed patients who are generally fitter 
to facilitate robotic procedures. The only prospective 
randomized controlled trial by Morino et al [26] did not 
show significant difference regarding BMI in the two 
groups with a limited number of patients. Aksoy et al. [19] 
for the first time compared RA versus LA in obese patients 
(BMI 35.4 ± 1.0 in robotic group vs 38.8 ± 0.8 Kg/m2 in 
laparoscopic group, p = 0.01) with no difference in 
perioperative outcomes. Authors believed that these results 
underlined the difficulties with robotic approach of 
obtaining and manteining appropriate exposure due to 
patient habitus and malposition of robotic trocars. Authors 
overcame this difficulty by either using more additional 
trocars or moving the position of the first assistant port. On 
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the contrary, Brunaud et al. [24] reported different results 
because the robotic approach offered several advantages in 
obese patients with no higher operative time when 
compared with LA. Surgical technique was comparable to 
laparoscopic surgery except for an additional trocar in RA 
[35, 36]. Agcaoglu et al. [23] performed a specific 
prospective study about posterior retroperitoneal 
adrenalectomy. Their hypothesis was that the two 
approaches, laparoscopic and robotic, would have had a 
similar operative outcome but that operative time would 
have been shorter with the robotic technique thanks to its 
more dexterous instrumentations. Statistical analysis 
showed similar operative time, with smaller (diameter < 6 
cm) selected adrenal lesion in robotic group, and RA was 
shorter only after the 10th procedure such as an effect of 
surgeon’s learning curve. Operative time, intraoperative 
blood loss and other complications and conversion rate 
were direct objective variables to evaluate the efficacy and 
safety of a new surgical technique. In a previous meta-
analysis by Tang et al. [32] there was a significant 
Figure 1: Systematic literature review to identify all studies that compared RA and LA.
Table 1: Characteristics of eligible studies
Study Country Study interval Study design Level of Evidence
Morelli et al. (2016) Italy 1994–2014 Retrospective 2b
Pahwa et al. (2015) India 2010–2013 Retrospective 3b
Brandao et al. (2014) USA 2004–2013 Retrospective 2b
Aliyev et al. (2013) USA 2000–2012 Prospective 2b
You et al. (2013) Korea 2009–2012 Retrospective 3b
Aksoy et al. (2013) USA 2003–2012 Prospective 2b
Pineda-Solis et al. (2013) USA NA Retrospective 3b
Agcaoglu et al. (2012) USA 2000–2011 Prospective 2b
Agcaoglu et al. (2012) 2012 2009–2011 Prospective 2b
Karabulut et al. (2012) USA 2008–2010 Prospective 2b
Brunaud et al. (2008) France 1996–2005 Prospective 2b
Wu et al. (2008) Taiwan 2003–2005 Prospective 2b
Morino et al. (2004) Italy 2002 RCT 2a
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difference in the operative time in favor of LA. Our results 
instead are agree with another study by Brandao et al. [33] 
that reported no statistically significant difference in this 
parameter. This evidence in our opinion was due to several 
different factors related to surgical team (robot setup and 
docking, resident surgeon or fellow). Agcaoglu et al. [21] 
reported a shorter operative time in RA in selected patients 
with large adrenal tumors. We described the controversies 
regarding the use of minimal invasive surgery in case of 
large adrenal masses because of technical limitations, 
longer operative time and increased blood loss [37, 38]. 
The critical difference between robotic and laparoscopic 
surgery was related to three-dimensional vision and 
wristed robotic instruments versus rigid laparoscopic 
devices. Karabulut et al. [22] focused their attention to 
time data on individual steps and skin-to-skin duration of 
procedures: on multivariate analysis they showed that RA 
performed by two staff surgeons was shorter than 
procedures with one staff surgeon and a fellow as first 
assistant with also fewer instruments changes and less 
need to clean the camera. Several studies reported that to 
keep the robot in a dedicated operating room and to do the 
other preparations of robotic platform during induction of 
anesthesia as well as initial laparoscopic phase of the 
procedure and the same learning curve of all members of 
surgical team reduced operative time. Brunaud et al. [24] 
observed no significant differences in operative time after 
the learning curve of 20 cases. On the other hand, 
Agcouglu et al. [21] reported a significant improvement in 
operative time after only the tenth procedure in the robot-
assisted group. All eligible articles showed a significant 
reduction of estimated blood loss in RA due to stereoscopic 
vision and to more precise dissection plane when using 
robotic arms. Although this difference was statistically 
significant, it was probably not clinically relevant. There 
were no significant differences in terms of conversion and 
overall complications rate, related to specific pathological 
results (e.g. pheocromocytoma, adrenocortical carcinoma, 
ACC) and to general clinical conditions rather than to the 
surgical procedure itself. From analysis of eligible studies 
conversion rate was similar in the two group. In the 
literature conversion rate for robotic approach was 
Figure 2: Demographics and preoperative characteristics. (A) Forest plot representing analysis of Body Mass Index. CI = 
confidence interval; MD = mean difference; SD = standard deviation; W = Weight. (B) Forest plot representing analysis of previous surgery 
rate. CI = confidence interval; OR = Odds Ratio; W = Weight.
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between 0–40%, instead was 0–10.5% for laparoscopic 
group. The highest conversion rate was of 40% derived 
from first randomized study by Morino [26]. The reasons 
of conversion were malposition of robotic trocars, 
prolonged operative time and difficulties to obtain accurate 
hemostasis. This last observation realistically was related 
to the initial lack of advanced energy source with typical 
use of monopolar scissor or bipolar forceps. We positively 
believe that technological advances and new multi-use 
instruments development will improve dissection reducing 
operative time, bleeding and complications. Morelli et al. 
[14] reported two vascular lesions (one vena cava and one 
left renal vein damage) among intraoperative 
complications in RA for large adrenal tumors managed by 
using sutures without the necessity to convert to 
laparoscopic or open surgery. Length of hospital stay was 
significant shorter in RA when compared to LA. In accord 
with different authors we thought that an accurate robotic 
surgical dissection and reduction in blood loss improved 
the postoperative recovery of these patients. On the other 
side robotic approach registered a longer operative timeand 
additional trocars that were in contrast with a reduced 
hospital stay. The difference could hide an operator 
relating bias explained with the positive expectations from 
a new procedure and the medical staff focused on the early 
hospital discharge [38, 39]. Only few studies of this 
research reported a long-term follow up for their patients. 
This was due to treatment, in large part, of benign adrenal 
diseases [14, 16, 17, 21, 24]. Still today increased costs 
represent the real drawbacks of the robotic procedures. In 
their prospective randomized controlled trial Morino et al. 
[26] reported higher cost of the robotic procedure without 
including the initial cost to buy the da Vinci system. The 
increased costs were mainly due to the use of semi-
disposable robotic instruments and longer operative time. 
Different studies [24, 19] calculated that the robotic 
procedures were 1.2–2.3 times more expensive than LA, 
but might take on a greater value in terms of marketing for 
the hospital. These authors concluded that capital and 
maintenance costs could be affordable at high-volume 
robotic surgery center reducing mean hospital stay and 
increasing the use of the robot by other surgical services. 
Figure 3: Operative variable. (A) Forest plot representing analysis of operative time. CI = confidence interval; MD = mean difference; 
SD = standard deviation; W = Weight; (B) Forest plot representing analysis of estimated blood loss. CI = confidence interval; MD = mean 
difference; SD = standard deviation; W = Weight.
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Figure 4: Surgical outcomes. (A) Forest plot representing analysis of complication rate. CI = confidence interval; RD = Risk Difference; 
SD = standard deviation; W = Weight; (B) Forest plot representing analysis of conversion rate. CI = confidence interval; OR = Odds 
Ratio;W = Weight; (C) Forest plot representing analysis of length of hospital stay. CI = confidence interval; MD = mean difference; SD = 
standard deviation; W = Weight.
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CONCLUSIONS
This study is a systematic literature review with meta-
analysis, but we must consider some limitations. The studies 
reviewed are retrospective and prospective, but only one 
is a randomized controlled trial that shows initial data of 
limited number of patients. The use of retrospective studies 
increases the possibility of selection bias with doubts in 
interpreting results. On the other hand the authors have 
different surgical experience and this can reflect different 
outcomes. Most of the studies take into consideration only 
benign adrenal pathology with no long-term follow-up. In 
literature we find other reviews and meta-analysis regarding 
initial, limited experience with robotic adrenalectomy. The 
reason for a new meta-analysis is due to rapid evolving of 
robotic technology and increased experience of dedicated 
surgeon with improved clinical outcomes. This present 
meta-analysis includes 798 patients: 379 underwent to RA 
(cases group) and 419 treated with LA (controls group). 
Our aim is that to evaluate demographic characteristics, 
operative parameters and clinical outcomes between RA 
and LA. RA is a safe and feasible technique with reduced 
blood loss and shorter hospital stay than LA. Laparoscopic 
approach seems to be a more rapid technique when 
comparing to RA, although recent studies demonstrate a 
significant operative time reduction in RA with the learning 
curve improvement and the development of new surgical 
technology and advanced energy source.
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